The DNA repair-blocking drug adavosertib shrinks tumors in nearly one-third of patients in clinical trial data to be shared at the Society for Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200423212610.htm
No comments:
Post a Comment